GelStat Corporation 

(Public, OTC:GSAC)   Watch this stock   
Find more results for STAT

Key stats and ratios

Q3 (Sep '05) 2004
Net profit margin -1442.31% -2540.00%
Operating margin -1357.69% -2464.90%
EBITD margin - -2456.33%
Return on average assets -154.27% -328.13%
Return on average equity -305.10% -521.84%
Employees 11 -

Address

1650 West 82nd Street Suite 1200
Bloomington, MN 55431
United States - Map
+1-952-8814105 (Phone)

Website links

GelStat Corporation discussions

  View all discussions »

Description

GelStat Corporation (GelStat), formerly known as Developed Technology Resource, Inc., is a consumer healthcare company involved in development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. Development efforts are focused on its own products that address global markets. Its products include GelStat Arthritis, GelStat Sinus and GelStat Sleep. GelStat intends to market and distribute its products primarily through drug stores and pharmacies, food stores and mass merchandise retailers. Effective April 30, 2003, the Company acquired GelStat Corp. (GC) as a wholly owned subsidiary. On March 17, 2004, GS Corp. was merged into its parent company, GelStat Corporation. During the year ended December 31, 2004, the Company established a subsidiary called GS Pharma, Inc.

Officers and directors

Michael Chavanu
Chairman of the Board
Gerald N. Kieft II
Chief Executive Officer
William R. Colucci
President, Director
Age: 68
James W. Higgins
Executive Vice President
Age: 48
Arthur Pirrone
Vice President, Domestic Sales & Marketing
Age: 61
Adrian Graham Goldfarb
Director
Age: 51